We finally achieved a US patent, covering the galangal granulate which we use in Punalpin and Punalpin PLUS. The granulate is characterized by a high content of the active compound acetoxychavicol acetate (ACA) and a long shelf life. The application was submitted to the US patent authority (USPTO) back in 2014, so it’s been a […]
Punalpin® is now sold in the Netherlands and Flanders by the Dutch company Atalis. Atalis is headed by Gerwin Smit who has a strong scientific background from the Delft University of Technology. We are looking much forward to the co-operation with Atalis!
We are now launching Punalpin® PLUS in a new version which covers 1 month’s treatment (180 tablets). The idea is that new users should be able to test the product without having to buy tablets for 3 months of consumption at one time. We still recommend treatment with Punalpin® PLUS for at least 90 days to […]
A new major meta-analysis conducted by an international team of researchers shows that sperm count (the number of semen cells) in men living in the Western world has fallen dramatically over the past 40 years. The meta-analysis is based on 185 studies and shows that on average, there has been a decrease of 50-60% in […]
We’re now almost ready with our new product Punalpin Plus! Punalpin Plus is a fertility product for optimization of sperm quality. The product contains pomegranate and greater galangal in the same doses as in our first product, Punalpin, and furthermore selenium, zinc and aronia have been added. Selenium and zinc The content of selenium […]
On the 2nd and 3rd of September, Nerthus participated in European Food Venture Forum in Aarhus. Together with 7 other innovative, European food companies Nerthus won an award for the project with the most potential. Altogether 32 European food companies had been selected for the competition. The award gives access to a final competition in Düsseldorf later this […]
In July 2014 we submitted a health claim application to the European Food Safety Authority (EFSA) and the EU Commission regarding the physiological effect of the two ingredients in Punalpin® (pomegranate and galangal). The purpose with this application was to achieve the right to claim the ingredients in Punalpin, i.e. to tell the customers, which […]
Punalpin differs from many other dietary supplements in that it was actually tested in a clinical study before marketing. The clinical study is of high standard (a so-called randomized, doubleblinded, placebo-controlled study) and includes 66 study participants. The positive result of the study has now been published in the international, peer-reviewed journal Plos One.
In July we submitted an application to EFSA (the European Food Safety Authority) regarding the authorization of a health claim on our combination of pomegranate extract and galangal rhizome. In other words, we apply for permission to tell about the physiological effect of our specific combination of pomegranate extract and galangal rhizome. In the EU […]